| Aug 21 |
Pacific Biosciences: Cash Rich, Revenue Poor, Still A 'Sell'
|
| Aug 21 |
Pacific Biosciences: A Speculative Play On Long-Read Genomics Sequencing
|
| Aug 12 |
Analyst Scoreboard: 5 Ratings For Pacific Biosciences
|
| Aug 12 |
Pacific Biosciences (PACB) Upgraded to Buy: Here's Why
|
| Aug 9 |
Pacific Biosciences of California Second Quarter 2024 Earnings: Misses Expectations
|
| Aug 8 |
PacBio (PACB) Q2 Earnings Beat Estimates, Revenues Down Y/Y
|
| Aug 8 |
Peering Into Pacific Biosciences's Recent Short Interest
|
| Aug 7 |
Compared to Estimates, Pacific Biosciences (PACB) Q2 Earnings: A Look at Key Metrics
|
| Aug 7 |
Pacific Biosciences of California, Inc. 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 7 |
Pacific Biosciences of California, Inc. (PACB) Q2 2024 Earnings Call Transcript
|
